GlaxoSmithKline PLC
LSE:GSK
GlaxoSmithKline PLC
LSE:GSK
Price:
1 705 GBX
1.91%
Market Closed
Updated:
May 2, 2024
GlaxoSmithKline PLC
Revenue
|
GlaxoSmithKline PLC
Revenue Peer Comparison
Comparables:
AZN
VRNA
INDV
HIK
DPH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£30.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$45.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Revenue
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Revenue
£761.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is GlaxoSmithKline PLC's Revenue?
Revenue
30.3B
GBP
30.3B
GBP
Based on the financial report for Dec 31, 2023, GlaxoSmithKline PLC's Revenue amounts to 30.3B GBP.
What is GlaxoSmithKline PLC's Revenue growth rate?
Revenue CAGR 10Y
2%
2%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for GlaxoSmithKline PLC have been 8% over the past three years , and 2% over the past ten years .
You don't have any saved screeners yet
